LPS priming before plaque deposition impedes microglial activation and restrains Aß pathology in the 5xFAD mouse model of Alzheimer′s disease

被引:11
作者
Yang, Yiyi [1 ,5 ]
Garcia-Cruzado, Marta [1 ]
Zeng, Hairuo [1 ]
Camprubi-Ferrer, Lluis [1 ]
Bahatyrevich-Kharitonik, Bazhena [1 ,2 ,4 ]
Bachiller, Sara [1 ,2 ,3 ]
Deierborg, Tomas [1 ,5 ]
机构
[1] Lund Univ, Dept Expt Med Sci, Expt Neuroinflammat Lab, Lund, Sweden
[2] Univ Seville, Virgen del Rocio Univ Hosp, Inst Biomed Seville IBiS, CSIC, Seville, Spain
[3] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Seville, Spain
[4] Univ Seville, Fac Pharm, Dept Biochem & Mol Biol, Seville, Spain
[5] Lund Univ, Expt Med Sci, Neuroinflammat, BMC B11,Solvegatan 19, S-22362 Lund, Sweden
基金
瑞典研究理事会;
关键词
LPS; Priming; Innate immune memory; Microglia; ss-amyloid pathology; Neuroinflammation; Long-term effects; Systemic inflammation; Proteomics; HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC FACTOR; PREFRONTAL CORTEX; PROGRESSION; TURNOVER; PROTEIN; MICE; NEURODEGENERATION; HYPERACTIVITY; INFLAMMATION;
D O I
10.1016/j.bbi.2023.07.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Microglia have an innate immunity memory (IIM) with divergent functions in different animal models of neurodegenerative diseases, including Alzheimer's disease (AD). AD is characterized by chronic neuroinflammation, neurodegeneration, tau tangles and ss-amyloid (A ss) deposition. Systemic inflammation has been implicated in contributing to the progression of AD. Multiple reports have demonstrated unique microglial signatures in AD mouse models and patients. However, the proteomic profiles of microglia modified by IIM have not been well-documented in an AD model. Therefore, in the present study, we investigate whether lipopolysaccharide (LPS)-induced IIM in the pre-clinical stage of AD alters the microglial responses and shapes the neuropathology. We accomplished this by priming 5xFAD and wild-type (WT) mice with an LPS injection at 6 weeks (before the robust development of plaques). 140 days later, we evaluated microglial morphology, activation, the microglial barrier around A ss, and A ss deposition in both 5xFAD primed and unprimed mice. Priming induced decreased soma size of microglia and reduced colocalization of PSD95 and Synaptophysin in the retrosplenial cortex. Priming appeared to increase phagocytosis of A ss, resulting in fewer Thioflavin S+ A ss fibrils in the dentate gyrus. RIPA-soluble A ss 40 and 42 were significantly reduced in Primed-5xFAD mice leading to a smaller size of MOAB2(+) A ss plaques in the prefrontal cortex. We also found that A ss-associated microglia in the Primed-5xFAD mice were less activated and fewer in number. After priming, we also observed improved memory performance in 5xFAD. To further elucidate the molecular mechanism underlying these changes, we performed quantitative proteomic analysis of microglia and bone marrow monocytes. A specific pattern in the microglial proteome was revealed in primed 5xFAD mice. These results suggest that the imprint signatures of primed microglia display a distinctive phenotype and highlight
引用
收藏
页码:228 / 247
页数:20
相关论文
共 50 条
  • [31] Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer's Disease
    Lim, Jeremiah K. H.
    Li, Qiao-Xin
    He, Zheng
    Vingrys, Algis J.
    Chinnery, Holly R.
    Mullen, Jamie
    Bui, Bang V.
    Nguyen, Christine T. O.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [32] Synthetic PPAR Agonist DTMB Alleviates Alzheimer’s Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
    Eunji Oh
    Jeong-Hwa Kang
    Kyung Won Jo
    Won-Sik Shin
    Young-Hun Jeong
    Byunghee Kang
    Tae-Young Rho
    So Yeon Jeon
    Jihoon Lee
    Im-Sook Song
    Kyong-Tai Kim
    Neurotherapeutics, 2022, 19 : 1546 - 1565
  • [33] Fatty acid amide hydrolase gene inactivation induces hetero-cellular potentiation of microglial function in the 5xFAD mouse model of Alzheimer's disease
    Arnanz, Maria Andrea
    Ferrer, Maria
    Grande, Maria Teresa
    Esteban, Samuel Ruiz de Martin
    Ruiz-Perez, Gonzalo
    Cravatt, Benjamin F.
    Mostany, Ricardo
    Lobo, Victor Javier Sanchez-Arevalo
    Romero, Julian
    Martinez-Relimpio, Ana Maria
    GLIA, 2025, 73 (02) : 352 - 367
  • [34] Dietary Fiber and Microbiota Metabolite Receptors Enhance Cognition and Alleviate Disease in the 5xFAD Mouse Model of Alzheimer's Disease
    Zhou, Yichen
    Xie, Liang
    Schroder, Jan
    Schuster, Iona S.
    Nakai, Michael
    Sun, Guizhi
    Sun, Yu B. Y.
    Marino, Eliana
    Degli-Esposti, Mariapia A.
    Marques, Francine Z.
    Grubman, Alexandra
    Polo, Jose M.
    Mackay, Charles R.
    JOURNAL OF NEUROSCIENCE, 2023, 43 (37) : 6460 - 6475
  • [35] INCREASED FRAGMENTATION OF SLEEP-WAKE CYCLES IN THE 5XFAD MOUSE MODEL OF ALZHEIMER'S DISEASE
    Sethi, M.
    Joshi, S. S.
    Webb, R. L.
    Beckett, T. L.
    Donohue, K. D.
    Murphy, M. P.
    O'Hara, B. F.
    Duncan, M. J.
    NEUROSCIENCE, 2015, 290 : 80 - 89
  • [36] Altered Brain Leptin and Leptin Receptor Expression in the 5XFAD Mouse Model of Alzheimer's Disease
    Pratap, Anishchal A.
    Holsinger, R. M. Damian
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 15
  • [37] The presymptomatic treatment with 3HFWC nanosubstance decreased plaque load in 5XFAD mouse model of Alzheimer's disease
    Perovic, Milka
    Ciric, Jelena
    Matovic, Valentina
    Srbovan, Maja
    Koruga, Djuro
    Kanazir, Selma
    Ivkovic, Sanja
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (03)
  • [38] Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer's Disease
    Karaahmet, Berke
    Olschowka, John A.
    O'Banion, M. Kerry
    PHARMACEUTICS, 2023, 15 (07)
  • [39] Microarray microRNA profiling of urinary exosomes in a 5XFAD mouse model of Alzheimer's disease
    Song, Zhiqi
    Qu, Yajin
    Xu, Yanfeng
    Zhang, Ling
    Li Zhou
    Han, Yunlin
    Zhao, Wenjie
    Yu, Pin
    Zhang, Yu
    Li, Xianglei
    Qin, Chuan
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2021, 4 (03) : 233 - 242
  • [40] Dietary Wheat Amylase Trypsin Inhibitors Impact Alzheimer's Disease Pathology in 5xFAD Model Mice
    Guilherme, Malena dos Santos
    Zevallos, Victor F.
    Pesi, Aline
    Stoye, Nicolai M.
    Vu Thu Thuy Nguyen
    Radyushkin, Konstantin
    Schwiertz, Andreas
    Schmitt, Ulrich
    Schuppan, Detlef
    Endres, Kristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 17